As of the close on Friday,$S&P/ASX 200(XJO.AU)$ closed at 6,978.20 points, up 3.12% in the past 5 days.
During the last 5 trading days, $Block Inc(SQ2.AU)$ added 21.11%; $NewMarket(NEU)$ was up 19.75%; $Inghams Group(ING.AU)$ rose 17.22%; and $Polynovo(PNV.AU)$ increased 13.60%; $Citizens(CIA)$ was up 12.82%
1. Payment services provider $Block Inc(SQ2.AU)$ surged 21.11%
The company beat Q3 earnings, raises guidance and also announces a $1 bln stock buyback.
Revenue was $5.62 bln, higher than $5.43 bln
Bitcoin revenue reached $2.42 bln, up 37% YoY
Adjusted EBITDA guidance raised to $2.4 bln,higher than expected $1.94 bln.
2. $Neuren Pharma(NEU.AU)$ up 19.75%: DAYBUE, Rett syndrome drug, sales tripled
The sales of its Rett syndrome drug, DAYBUE almost tripled in a quarter.
According to the release, its partner $ACADIA Pharmaceuticals(ACAD)$ delivered Q3 Daybue net sales in US of US$66.9 mln.
Guidance for net sales in Q4 2023: US$80 mln - US$87.5 mln.
Anticipated royalties to Neuren are A$10.4 mln for Q3 and A$12.5 mln to A$13.7 mln for Q4.
3. Poultry company $Inghams Group(ING.AU)$ surges 17.22% following a positive trading update for the half-year
The company reported a recovery in operational performance across various metrics, including farming, processing, and wholesale pricing.
Strong demand for poultry products and an accelerated recovery in New Zealand contributed to the positive outlook.
4. Medical devices provider $Polynovo(PNV.AU)$ rebounds 13.60%
PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally.
With no price-sensitive news, PNV seems to rebound with the broader market after the continued declines ceased on 24th Oct.
5. $Champion Iron Ltd(CIA.AU)$ added 12.82%: Strong momentum after earnings
Champion Iron showed strong momentum after earnings released on 26th Oct.
The company produced a record amount of high-grade iron concentrate and selling more iron-ore concentrate than before.
Bloom Lake mine in Quebec achieved its expanded nameplate capacity of 15 million tonnes a year in the last 30 days and reported record production.
Comments
Why does Neuren Pharma not paying dividend despite being in profit. Also what can we expect in Q4?